Showing posts with label bristol meyers squibb. Show all posts
Showing posts with label bristol meyers squibb. Show all posts

Monday, November 15, 2010

Entire Bristol Myers Squibb Shipment Stolen

As reported earlier in Secure Pharma Chain Blog, according to Freightwatch International, Bristol Myers Squibb’s entire truckload of pharmaceuticals, valued at several million dollars was stolen from a rest area in Florence, Kentucky on November 11th.

Products in the shipment included Avapro, Avalide, Coumadin, Abilify, Reyataz and Plavix.

The stolen truck - which was plain white with no unique markings - was taken from a rest area in Florence, Kentucky, after being left unattended for approximately 15 minutes by the driver and a passenger.

The driver had been forced to park some distance away from the main facility because the rest area was full. Evidence from the scene indicated the thieves made entry by breaking the lower window on the passenger side.

FreightWatch has recorded 27 pharmaceutical theft incidents year-to-date in the United States, with an average loss per shipment of $5.1M, up from $4M in 2009.

Secure Pharma Chain is encouraging all members of the pharmaceutical supply chain to be vigilant in protecting their inventories from all suspicious offers of medications from unknown sources. Stolen products are especially dangerous in that the actual drugs will not be handled properly-while the product containers will likely be emptied of the legitimate drugs- replaced with counterfeit drugs and sold within the supply chain.

The most effective solution for the interdiction of fraudulent, adulterated, sub-standard and counterfeit drugs is verifying the drug inside a sealed container with an material authentication technology.

To learn about material authentication technologies, visit: http://www.xstreamsystems.net/

Wednesday, July 14, 2010

Bristol-Myers Squibb Recalls Lots of Coumadin


Bristol-Myers Squibb is recalling eight production lots of its anti-clotting drug Coumadin because the amount of the active ingredient in the drug could change.

Bristol-Myers Squibb (BMS) is recalling a total of 144,672 1-milligram tablets of Coumadin, all of which were distributed in the U.S. The recall includes five production lots of Coumadin hospital unit doses and three lots of physician samples. All the tablets were distributed in blisterpacks, no bottled medicine or other doses are involved.

The company said the recall is a precaution, and no side effects have been reported.

BMS said the amount of isopropanol in the tablets could change over time. Isopropanol, or isopropyl alcohol, is used to keep the drug's active ingredient in a crystalline state. The changing levels of isopropanol could increase or reduce the amount of the active ingredient in the tablets.

Secure Pharma Chain Blog endorses the use of authentication technologies to verify the efficacy, quality and effectiveness of pharmaceutical products inside their unit of sale containers within the supply chain.

Thursday, January 28, 2010

Bloomberg: Interpol Investigation Leads to Drug Seizures, Arrests in Asia


Bloomberg News has posted an online story reporting on a huge seizure of millions of counterfeit unit of sale packs of counterfeit medications. The operation coded named Operation Storm II was coordinated by Interpol and included counterfeit medications from the branded manufacturers Pfizer, Bristol-Meyers Squibb and Teva.

The entire Bloomberg News story appears below:

Police seized more than 20 million packs of counterfeit medicines, arrested at least 33 people and closed more than 100 illegal pharmacies in a series of raids in eight Southeast Asian nations coordinated by Interpol.

Counterfeit versions of Pfizer Inc.’s Viagra for erectile dysfunction, Bristol-Myers Squibb Co.’s blood thinner Plavix and Teva Pharmaceutical Industries Ltd.’s morning-after pill Plan B were among the products seized, Aline Plancon, an Interpol officer who coordinated the raids, said Jan. 26 in an e-mail from Jakarta. The haul also included fake aspirin, antibiotics, malaria treatments and hair-loss medicines, she said.

The seizures and arrests, part of an investigation called Operation Storm II, are the second round of raids in two years in Asia as international and local police crackdown on widening sales of fake medicines.

Asia is the world’s biggest producer of all counterfeit products, the Organization for Economic Cooperation and Development said in 2007 report. About 40 percent of 1,047 arrests related to fake drugs worldwide in 2008 were made in Asia, according to the Washington-based Pharmaceutical Security Institute.

In raids between July and November, police in Cambodia, China, Laos, Indonesia, Myanmar, Singapore, Thailand and Vietnam seized more than 12.2 million packs of fake drugs, Plancon said. An additional 8 million packs of medicines that had passed their expiry dates, were unregistered, or had been diverted from their intended destinations were also confiscated, she said.

Authorities from the eight countries involved plan to form a network to exchange information; coordinate enforcement and forensic investigations; and raise awareness in the region, Plancon said. Interpol is also creating a unit focused on fighting fake drugs, she said.
The new unit will help “dismantle the transnational criminals who threaten lives,” Plancon said. “This crime is a plague that needs to be addressed seriously and consistently in each and every country and region of the world.”

In 2008, police seized more than $6.7 million of counterfeit medicines and made 27 arrests in 200 raids across the region as part of Operation Storm I.

To read learn more about anti-counterfeiting technologies that protect the pharmaceutical supply chain, visit: www.xstreamsystems.net.

To read the entire Bloomberg post, follow this link:
http://www.bloomberg.com/apps/news?pid=20601080&sid=aktGpE2o.ohM